Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Commercial Insight: Migraine' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Anticonvulsants Market to 2016 Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies |
Jan 2011 | £2,215 | 100% |
| The Global Pain Therapeutics Market 4th Edition: Market Trends & R&D Insights |
Nov 2010 | £1,105 | 90% |
| Stakeholder Opinions: Diagnostics in Neurology Predictive Biomarkers Expand Drug Revenues |
Jul 2008 | £2,400 | 74% |
| New Drug Futures 2009 | Jan 2012 | £1,995 | 59% |
| Pipeline Insight: Breakthrough Pain Fast-acting players will capture majority market share |
Nov 2006 | £7,210 | 56% |
| Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015 |
Jan 2011 | £995 | 47% |
- Results 1 - 6 of 6
-
-
- 1
-
-
